profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
rensketenham,Renske,ten Ham,"Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht",https://media.licdn.com/dms/image/C5603AQE9blZqquoEeg/profile-displayphoto-shrink_800_800/0/1601541856577?e=1697673600&v=beta&t=cBcAWwyeKcM_zodHufup2zzbyJPctmwWWWI-veQY_JA,https://media.licdn.com/dms/image/C4D16AQFbwLPQMPfBbA/profile-displaybackgroundimage-shrink_350_1400/0/1516938249988?e=1697673600&v=beta&t=al9kX-n1_GIRRVFZafefulXIHaAr3Gq7xYq67srazPk,personal,ACoAAASBCtoBDwoxquoJIp-muDqFRTht9kuPO8E,75565786,,"Renske ten Ham is an assistant professor at the UMC Utrecht in the Netherlands and specializes in health economics & health technology assessment (HTA) of regenerative medicines, including gene and cell-based therapies. Trained as a pharmacist and with an MSc in HTA, she holds a PhD in Drug Innovation titled: “Development, market authorization and market access of gene- and cell-based therapies”.

At the Julius Center Renske is lead of the Regenerative Medicines (RM) team within the Health Economic Evaluation-group. She strives to increase translation of RM and (academic) gene and cell-based therapies towards implementation in healthcare services. In doing so her research focusses on payment models, development cost, (early) economic evaluations and business models. She aims to contribute to better understanding of the fit between innovative therapies and existing development frameworks. This is not only relevant for RM but also for future biomedical innovations.","{'country': 'Netherlands', 'short': 'Amsterdam, North Holland', 'city': 'Amsterdam', 'state': 'North Holland', 'default': 'Amsterdam, North Holland, Netherlands'}",False,False,[],"{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'Dutch', 'proficiency': 'NATIVE_OR_BILINGUAL'}, {'name': 'English', 'proficiency': 'NATIVE_OR_BILINGUAL'}]}",Hospital & Health Care,"[{'date': {'start': {'month': None, 'day': None, 'year': 2016}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'school': {'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': 'https://www.linkedin.com/school/universiteit-utrecht/'}, 'degree_name': 'Doctor of Philosophy - PhD', 'field_of_study': 'Drug Innovation'}, {'date': {'start': {'month': None, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'school': {'name': 'University of Glasgow', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQGzuO5pfplanQ/company-logo_400_400/0/1663661768903?e=1700092800&v=beta&t=G7ZYQNpXENgzcs60XKIM5ThhwJKn5XFuxq5e58lI-VY', 'url': 'https://www.linkedin.com/school/university-of-glasgow/'}, 'degree_name': 'MSc', 'field_of_study': 'Health Technology Assessment'}, {'date': {'start': {'month': None, 'day': None, 'year': 2014}, 'end': {'month': None, 'day': None, 'year': 2015}}, 'school': {'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': 'https://www.linkedin.com/school/universiteit-utrecht/'}, 'degree_name': 'Young Innovators League', 'field_of_study': 'Honours Degree, Innovation,Entrepeneurship'}, {'date': {'start': {'month': None, 'day': None, 'year': 2013}, 'end': {'month': None, 'day': None, 'year': 2014}}, 'school': {'name': 'University of California, San Francisco', 'logo': 'https://media.licdn.com/dms/image/D560BAQHQQEHM5q7X-g/company-logo_400_400/0/1689280832395?e=1700092800&v=beta&t=ki7K5TNTjACT4-d9Lymdi144tfr-aOfhS7A1RajIEME', 'url': 'https://www.linkedin.com/school/ucsf/'}, 'degree_name': 'Program for Outcomes, Pharmaceutical Economics, and Policy Studies ', 'field_of_study': None}, {'date': {'start': {'month': None, 'day': None, 'year': 2012}, 'end': {'month': None, 'day': None, 'year': 2015}}, 'school': {'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': 'https://www.linkedin.com/school/universiteit-utrecht/'}, 'degree_name': 'PharmD', 'field_of_study': 'Pharmacy'}, {'date': {'start': {'month': None, 'day': None, 'year': 2007}, 'end': {'month': None, 'day': None, 'year': 2012}}, 'school': {'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': 'https://www.linkedin.com/school/universiteit-utrecht/'}, 'degree_name': 'Bachelor of Science (BSc)', 'field_of_study': 'Pharmaceutical Sciences'}, {'date': {'start': {'month': None, 'day': None, 'year': 2001}, 'end': {'month': None, 'day': None, 'year': 2007}}, 'school': {'name': 'Utrechts Stedelijk Gymnasium', 'logo': None, 'url': None}, 'degree_name': 'Gymnasium', 'field_of_study': 'Natuur & Gezondheid'}]",[],"[{'title': 'Greiner Award for the best thesis defended in 2020&2021', 'description': None, 'issuer': 'Netherlands Society of Gene and Cell Therapy', 'date': {'month': 6, 'day': None, 'year': 2022}}, {'title': 'Publication featured as Trends Editors Pick 2020', 'description': 'The editors of the Trends Journals each select the publications which they find most thought provoking. These are featured and included in the list of 2020 editors picks.\n\nAwarded publication: Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection. \nPublished in Trends in Pharmacological Sciences, Feb 2020', 'issuer': 'Trends in Pharmacological Sciences', 'date': {'month': None, 'day': None, 'year': 2020}}, {'title': 'Publication granted Editors pick', 'description': 'Each month a selection of publications are featured as editors pick by the journals editorial board. \n\nAwarded publication: A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature.\nPublished in Value in Health, Sept 2020', 'issuer': 'Value in Health', 'date': {'month': None, 'day': None, 'year': 2020}}, {'title': 'Best Scientific Poster', 'description': 'Awarded poster: Challenges in Advanced Therapy Medicinal Product Development\n\n\n', 'issuer': 'TOPRA Conference 2019', 'date': {'month': 10, 'day': None, 'year': 2019}}]",[],[],[],"[{'name': 'Gene therapies, uncertainty and decision-making: thinking about the last mile at the first step', 'publisher': 'Expert Rev Pharmacoecon Outcomes Res', 'url': 'https://doi.org/10.1080/14737167.2023.2245138', 'date': {'month': None, 'day': None, 'year': 2023}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma', 'publisher': 'New England journal of Medicine', 'url': 'https://www.nejm.org/doi/full/10.1056/NEJMoa2210233?query=featured_home', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Kostprijs-plusmodel geeft inzicht in reelere prijzen gentherapieen', 'publisher': 'Pharmaceutisch Weekblad', 'url': 'https://www.pw.nl/achtergrond/2022/kostprijs-plusmodel-geeft-inzicht-in-reele-prijzen-gentherapieen', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Gen- en celtherapieen zijn straks niet meer weg te denken [Interview]', 'publisher': 'Pharmaceutisch weekblad', 'url': 'https://www.pw.nl/achtergrond/2022/2018gen-en-celtherapieen-zijn-straks-niet-meer-weg-te-denken2019', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma', 'publisher': 'Cytotherapy', 'url': 'http://10.1016/j.jcyt.2022.09.002', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A', 'publisher': 'HemaSphere', 'url': 'https://journals.lww.com/hemasphere/Fulltext/2022/02000/Modeling_Benefits,_Costs,_and_Affordability_of_a.5.aspx', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Gen- en celtherapieën: de hobbelige route van lab naar de patiënt', 'publisher': 'Pharmaceutisch Weekblad', 'url': 'https://www.pw.nl/achtergrond/2022/gen-en-celtherapieen-de-hobbelige-route-van-lab-naar-de-patient', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England', 'publisher': 'Value in Health', 'url': 'https://doi.org/10.1016/j.jval.2021.09.012', 'date': {'month': None, 'day': None, 'year': 2021}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Estimation of manufacturing development costs of cell-based therapies: a feasibility study', 'publisher': 'Cytotherapy', 'url': 'https://www.isct-cytotherapy.org/article/S1465-3249(21)00004-9/fulltext', 'date': {'month': None, 'day': None, 'year': 2021}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients', 'publisher': 'Value in Health', 'url': 'https://www.sciencedirect.com/science/article/pii/S1098301520322117', 'date': {'month': None, 'day': None, 'year': 2021}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Increasing the information provided by probabilistic sensitivity analysis: The relative density plot', 'publisher': 'Cost Effectiveness and Resource Allocation', 'url': 'https://resource-allocation.biomedcentral.com/articles/10.1186/s12962-020-00251-7', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature', 'publisher': 'Value in health', 'url': 'https://www-sciencedirect-com.proxy.library.uu.nl/science/article/pii/S1098301520321197', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'The relative impact of urinary and sexual function versus bother on health utility for men with prostate cancer', 'publisher': 'JNCI Cancer Spectrum', 'url': 'https://academic.oup.com/jncics/advance-article/doi/10.1093/jncics/pkaa044/5843797', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings', 'publisher': 'Cytotherapy', 'url': 'https://www.celltherapyjournal.org/article/S1465-3249(20)30496-5/fulltext', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection', 'publisher': 'Trends in Pharmacological Sciences', 'url': 'https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(19)30271-8', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry', 'publisher': 'Eur Urol', 'url': 'https://www.sciencedirect.com/science/article/pii/S0302283819305366?via%3Dihub', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry', 'publisher': 'Clinical Genitourinary Cancer', 'url': None, 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe', 'publisher': 'Molecular Therapy', 'url': 'https://www.sciencedirect.com/science/article/pii/S2329050118300998', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen', 'publisher': 'Breast Cancer Res Treat', 'url': 'https://link.springer.com/article/10.1007%2Fs10549-018-4886-8', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}, {'name': 'Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology', 'publisher': 'JMIR Cancer', 'url': 'https://cancer.jmir.org/2018/1/e11/', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Renske', 'last_name': 'ten Ham', 'name': None, 'headline': 'Assistant Professor Health Technology Assessment at Julius Centrum, UMC Utrecht'}]}]",[],[],"[{'company': {'id': 8517, 'name': 'UMC Utrecht', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQG50uAl6TiV2g/company-logo_400_400/0/1638562574508?e=1700092800&v=beta&t=mTnteZlB6Kim5wFZ0jF1f833Vs7TDAOEL2ioXOZvP-0', 'url': 'https://www.linkedin.com/company/umcutrecht/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': None, 'day': None, 'year': 2021}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Utrecht, Netherlands', 'date': {'start': {'month': None, 'day': None, 'year': 2021}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'UMC Utrecht', 'description': 'Expertise: Health economics and health technology assessment of Regenerative Medicines (i.e., gene- and cell-based therapies, organoids among other innovations).', 'title': 'Assistant Professor Health Technology Assessment at Julius centrum', 'employment_type': None}]}, {'company': {'id': 166740, 'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': 'https://www.linkedin.com/school/universiteit-utrecht/', 'employees': {'start': 5001, 'end': 10000}}, 'date': {'start': {'month': None, 'day': None, 'year': 2016}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'profile_positions': [{'location': 'Utrecht Area, Netherlands', 'date': {'start': {'month': None, 'day': None, 'year': 2016}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'company': 'Utrecht University', 'description': 'Thesis topic: Development, market authorisation and market access of gene and cell-based therapies. Available via: https://dspace.library.uu.nl/handle/1874/402231.\n\nCoordinator and lecturer in the European Program for Pharmacovigilance and Pharmacoepidemiology (Eu2P) in the field of medicines benefit-risk assessment and pharmacoeconomics: www.eu2p.org.', 'title': 'PhD Candidate', 'employment_type': 'Full-time'}]}, {'company': {'id': 418166, 'name': 'KJT Group', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQEirmpxlB9Wjg/company-logo_400_400/0/1688068449177?e=1700092800&v=beta&t=9TYlP8K5rOqLTPFQCeuz712VCFI1ZLimSn1OsM4s1OA', 'url': 'https://www.linkedin.com/company/kjt-group/', 'employees': {'start': 51, 'end': 200}}, 'date': {'start': {'month': 11, 'day': None, 'year': 2015}, 'end': {'month': 12, 'day': None, 'year': 2016}}, 'profile_positions': [{'location': 'Amsterdam Area, Netherlands', 'date': {'start': {'month': 11, 'day': None, 'year': 2015}, 'end': {'month': 12, 'day': None, 'year': 2016}}, 'company': 'KJT', 'description': None, 'title': 'Research Associate - Market Access & HEOR', 'employment_type': None}]}, {'company': {'id': 34251, 'name': 'Zorginstituut Nederland', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQEx2xzThZVO-g/company-logo_400_400/0/1685603636240?e=1700092800&v=beta&t=zWDGdbxTubwOOQmZHiXsqXDoQ38hSWG1HJ1ToTw_GBo', 'url': 'https://www.linkedin.com/company/zorginstituutnederland/', 'employees': {'start': 201, 'end': 500}}, 'date': {'start': {'month': None, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': 2015}}, 'profile_positions': [{'location': 'Diemen', 'date': {'start': {'month': None, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': 2015}}, 'company': 'Zorginstituut Nederland', 'description': 'MSc Internship: Use of Real-World Data in Health Technology Assessment', 'title': 'Research Assistant', 'employment_type': None}]}, {'company': {'id': 3028, 'name': 'UCSF', 'logo': 'https://media.licdn.com/dms/image/D560BAQHQQEHM5q7X-g/company-logo_400_400/0/1689280832395?e=1700092800&v=beta&t=ki7K5TNTjACT4-d9Lymdi144tfr-aOfhS7A1RajIEME', 'url': 'https://www.linkedin.com/school/ucsf/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': None, 'day': None, 'year': 2013}, 'end': {'month': None, 'day': None, 'year': 2014}}, 'profile_positions': [{'location': 'San Francisco Bay Area', 'date': {'start': {'month': None, 'day': None, 'year': 2013}, 'end': {'month': None, 'day': None, 'year': 2014}}, 'company': 'University of California, San Francisco', 'description': 'MSc thesis: Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.', 'title': 'Junior Specialist', 'employment_type': None}]}, {'company': {'id': 4083, 'name': 'VU medisch centrum', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQHBs6rXsQYqGQ/company-logo_400_400/0/1528382070277?e=1700092800&v=beta&t=nNnEZWCFIyodLygtj5_yL79e9FKGOugqp1LUKOZKjdc', 'url': 'https://www.linkedin.com/company/amsterdamumc/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': None, 'day': None, 'year': 2010}, 'end': {'month': None, 'day': None, 'year': 2011}}, 'profile_positions': [{'location': 'Amsterdam Area, Netherlands', 'date': {'start': {'month': None, 'day': None, 'year': 2010}, 'end': {'month': None, 'day': None, 'year': 2011}}, 'company': 'Amsterdam UMC', 'description': 'BSc thesis: Adherence and patients’ experiences with the use of oral anticancer agents.', 'title': 'Research Assistent', 'employment_type': None}]}]","[{'date': {'start': {'month': None, 'day': None, 'year': 2020}, 'end': {'month': None, 'day': None, 'year': None}}, 'role': 'Precision Medicine and Advanced Therapies Special Interest Group', 'company': {'id': None, 'name': 'ISPOR—The Professional Society for Health Economics and Outcomes Research', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFjxoV4YtUzDA/company-logo_400_400/0/1545081312829?e=1700092800&v=beta&t=o-xvkyZGD7-vUnf90G-_-pEOEPOmLCvsGKjT_ehSLFE', 'url': 'https://www.linkedin.com/company/ispororg/'}, 'cause': 'HEALTH', 'description': None}, {'date': {'start': {'month': None, 'day': None, 'year': 2017}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'role': 'Board Member NVTAG and President Young-NVTAG', 'company': {'id': None, 'name': 'Nederlandse Vereniging voor Technology Assessment in de Gezondheidszorg (NVTAG)', 'logo': None, 'url': None}, 'cause': 'HEALTH', 'description': 'NVTAG is the Dutch association for medical technology assessment\nhttps://www.nvtag.nl/'}, {'date': {'start': {'month': None, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': 2016}}, 'role': 'President & Founder Student Chapter', 'company': {'id': None, 'name': 'ISPOR—The Professional Society for Health Economics and Outcomes Research', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFjxoV4YtUzDA/company-logo_400_400/0/1545081312829?e=1700092800&v=beta&t=o-xvkyZGD7-vUnf90G-_-pEOEPOmLCvsGKjT_ehSLFE', 'url': 'https://www.linkedin.com/company/ispororg/'}, 'cause': 'HEALTH', 'description': None}, {'date': {'start': {'month': 6, 'day': None, 'year': 2011}, 'end': {'month': 6, 'day': None, 'year': 2012}}, 'role': 'President', 'company': {'id': None, 'name': 'U.P.S.V. ""Unitas Pharmaceuticorum""\u200b', 'logo': 'https://media.licdn.com/dms/image/C560BAQFFc-54w26khw/company-logo_400_400/0/1542896545921?e=1700092800&v=beta&t=Mg2WJdASqiLImz1Lni7ZGL9RXcv4YMyc3slTgsR-9Ks', 'url': 'https://www.linkedin.com/company/u-p-s-v-unitas-pharmaceuticorum/'}, 'cause': 'EDUCATION', 'description': 'President of the Student Association for pharmacy student at Utrecht University. A full time position managing 1500 members and ~50 committee members. '}]","['Pharmaceutical Industry', 'Health Economics', 'Pharmaceutics', 'Pharmacology', 'Pharmacy', 'Life Sciences', 'Lifesciences', 'Clinical Trials', 'Clinical Research', 'Healthcare', 'Statistics', 'Biotechnology', 'SPSS', 'Dutch']",,,
